No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
Avadel Pharmaceuticals Plc's (NASDAQ:AVDL) Path To Profitability
Oppenheimer's Top SMID Ideas Within High-growth Themes
Avadel Pharmaceuticals to Join Russell 3000 Index
Oppenheimer Maintains Avadel Pharmaceuticals(AVDL.US) With Buy Rating, Maintains Target Price $29
Rodman & Renshaw Initiates Avadel Pharmaceuticals(AVDL.US) With Buy Rating, Announces Target Price $27
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading